Lipid apheresis: From a heroic treatment to routine clinical practice

Artificial Organs

Volumn 20, Issue 6, 1996, Pages 414-419

  Bosch, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

biocompatibility; heparin induced extracorporeal low density lipoprotein precipitation; lipid apheresis; lipoprotein(a); low density lipoprotein adsorption; low density lipoprotein cholesterol; low density lipoprotein hemoperfusion

Indexed keywords

BLOOD; CHOLESTEROL; DISEASES; HEART; LIPOPROTEINS; PATIENT TREATMENT;

HEMOPERFUSION; HEPARIN-INDUCED EXTRACORPOREAL LOW-DENSITY LIPOPROTEIN PRECIPITATION; LIPID APHERESIS; LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN(A); LOW DENSITY LIPOPROTEINS; LOW-DENSITY LIPOPROTEIN ADSORPTION; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; LOW-DENSITY LIPOPROTEIN HEMOPERFUSION;

BIOCOMPATIBILITY;

HEPARIN; LOW DENSITY LIPOPROTEIN;

APHERESIS; ATHEROSCLEROSIS; BIOCOMPATIBILITY; CONFERENCE PAPER; HEMOPERFUSION; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL;

EID: 0029977247     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04525.x     Document Type: Conference Paper

References (22)

1. de Gennes JL, Touraine R, Maunand B, Truffert J, Laudat P. Formes homozygotes cutanéo-tendineuses de xanthomatose hypercholesterolémique dans une observation familiale exemplaire - essai de plasmaphérèse à titre du traitement héroique. Société Médicale du Hôpital de Paris 1967;118: 1377-87.
2. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolemia. Lancet 1975;1:1208-11.
3. Lupien PJ, Moorjani S, Lou M, Brun D, Gagne C. Removal of cholesterol from blood by affinity binding to heparin-agarose: evaluation of treatment in homozygous familial hypercholesterolemia. Pediatr Res 1980;14:113-7.
4. Stoffel W, Demant T. Selective removal of apolipoprotein B containing serum lipoproteins from blood plasma. Proc Natl Acad Sci USA 1981;78:611-5.
5. Tanaka M, Nohara R, Yohode Y, Tsuyuguchi N, Suwo M, Doi T, Kanatsu K, Nagai H. Double-filtration plasmapheresis for a homozygous familial hypercholesterolemia. In: Oda T, ed, Therapeutic plasmapheresis (II). Schattauer Verlag New York, 1982:315-8.
6. Nosé Y, Usami M, Malchesky PS, Emura M, Horiuchi T. Clinical thermofiltration: initial application. Artif Organs 1985;9:425-7.
7. Kochinke F, von Baeyer H, Schwaner I, Schwerdtfeger R. Comparison of plasma fractionation filters and filtration techniques in the clinical practice of LDL-apheresis. Trans Am Soc Artif Organs 1986;32:388-91.
8. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoprotein. J Lipid Res 1983;24:904-9.
9. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of LDL by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-22.
10. Eisenhauer T, Schuff-Werner P, Armstrong VW, Müller U, Bosch T, Thiery J, Gurland HJ, Seidel D. Simultaneous heparin-induced extracorporeal LDL precipitation and haemodialysis: first clinical experience. Trans Am Soc Artif Intern Organs 1991;37:M494-M496.
11. Pokrovsky SN, Sussekov AV, Afanasieva OY, Adamova IY, Lyashikev AA, Kukharchuk VV. Extracorporeal immunoadsorption for the specific removal of lipoprotein(a) (Lp[a] apheresis): preliminary clinical data. Chem Phys Lipids 1994;67/68:323-30.
12. Bosch T, Schmidt B, Blumenstein M, Gurland HJ. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood. Artif Organs 1993;17: 640-52.
13. Bosch T, Seidel D, Gurland HJ. Efficacy of lipid apheresis: definitions and influencing factors. Int J Artif Organs 1995; 18:210-5.
14. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21.
15. Yokoyama S, Hayashi R, Kikkawa T, Tani N, Takada S, Hatanaka K, Yamamoto A. Specific sorbent of apoprotein B containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits. Arteriosclerosis 1984;4:276-82.
16. Bosch T, Schmidt B, Samtleben W, Gurland HJ. New LDL-adsorption column containing dextran sulfate: ex vivo clinical performance and biocompatibility. In: Oda T, Shiokawa Y, Inoue N, eds. Therapeutic plasmapheresis (VI). Cleveland: ISAO Press, 1987:576-80.
17. Bosch T, Blumenstein M, Dendorfer U, Samtleben W, Schmidt B, Gurland HJ. Klinische LDL-Adsorption an Dextransulfat mit automatischer on-line Adsorberregeneration bei Hyperlipoproteinämie. In: Gurland HJ, Koch KM, Schoeppe W, Scigalla P, eds. Innovative Aspekte der Klinischen Medizin I, Berlin: Springer Verlag, 1989:38-51.
18. Bosch T, Samtleben W, Thiery J, Gurland HJ, Seidel D. Reverse flux filtration: a new mode of therapy improving the efficacy of heparin induced extracorporeal LDL precipitation in hemodialysis patients. Int J Artif Organs 1993;16: 75-85.
19. Bosch T, Thiery J, Gurland HJ, Seidel D. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure. Nephrol Dial Transplant 1993;8:1350-8.
20. Bosch T, Schmidt B, Kleophas W, Tersteegen B, Leschkem, Otto V, Passlick-Deetjen J, Gurland HJ. Clinical efficacy and biocompatibility of the first LDL-adsorber compatible with human whole blood. Int J Artif Organs 18:417(1995).
21. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. Br Med J Clin Res Ed 1985; 291:1671-3.
22. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Thorgeirsson G, Pyörälä K, Miettinen T, Wilhelmson L, Olsson AG, Wedel H. A randomized study on cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-9.